Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization

Ocugen has secured exclusive regional rights to an intranasally delivered COVID-19 vaccine, positioning it to advance an intervention that already has emergency authorization in India toward the market in other parts of the world.